Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 21.26 as of Thursday, July 30, 2026.
Forward PE Ratio (21.26) = Close Price ($229.12) / Consensus Forward EPS ($10.78)
FORWARD PE RATIO
21.26
SECTOR MEDIAN · HEALTHCARE
19.43
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+9.42%
vs the sector median at left
Cardinal Health, Inc.
Market Cap
$53.66B
Forward PE Ratio
21.26
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cardinal Health, Inc. (CAH) | $53.66B | 21.26 |
| Edwards Lifesciences Corporation (EW)vs › | $49.38B | 28.57 |
| Becton, Dickinson and Company (BDX)vs › | $61.01B | 13.35 |
| Cencora, Inc. (COR)vs › | $61.99B | 17.92 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.95B | 38.90 |
| Humana Inc. (HUM)vs › | $43.93B | 40.67 |
| IQVIA Holdings Inc. (IQV)vs › | $41.35B | 19.16 |
| Agilent Technologies, Inc. (A)vs › | $39.63B | 23.17 |
| Boston Scientific Corporation (BSX)vs › | $68.43B | 13.72 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $38.27B | 38.45 |
Trailing P/E
35.0
reported TTM EPS
Forward P/E
21.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.78 implies +64.8% EPS growth vs the reported trailing $6.54.
At today's $229.12 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $12.07 | $11.70 – $12.44 | 10 | 19.0x |
| 2028-06-30 | $13.59 | $10.53 – $15.58 | 5 | 16.9x |
| 2029-06-30 | $15.27 | $13.17 – $16.95 | 4 | 15.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
